Radiotherapy planning of lymphomas: role of metabolic imaging with PET/CT

被引：3

作者：

McKay, Michael J. ^{[1
,2
,3
]}

Taubman, Kim L. ^{[4
]}

Lee, Szeting ^{[5
]}

Scott, Andrew M. ^{[2
,5
,6
]}

机构：

[1] North West Canc Ctr, Northern Canc Serv, Burnie, Tas 7320, Australia

[2] La Trobe Univ, Sch Canc Med, Olivia Newton John Canc Res Inst, Melbourne, Vic, Australia

[3] Univ Tasmania, Northwest Reg Hosp, Rural Clin Sch, Burnie, Tas 7320, Australia

[4] St Vincents Hosp, Dept Med Imaging, Fitzroy, Vic 3065, Australia

[5] Austin Hlth, Dept Mol Imaging & Therapy, 145 Studley Rd, Heidelberg, Vic 3084, Australia

[6] Univ Melbourne, Fac Med, Melbourne, Vic 3052, Australia

来源：

ANNALS OF NUCLEAR MEDICINE | 2022年 / 36卷 / 02期

关键词：

Lymphoma; Radiotherapy planning; PET; Metabolic imaging; POSITRON-EMISSION-TOMOGRAPHY; INTENSITY-MODULATED RADIOTHERAPY; STAGE HODGKIN-LYMPHOMA; INVOLVED-NODE RADIOTHERAPY; INSPIRATION BREATH-HOLD; RADIATION-THERAPY; FDG-PET; FOLLICULAR LYMPHOMA; RESPONSE ASSESSMENT; IMPACT;

D O I：

10.1007/s12149-021-01703-7

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Accurate target delineation is an absolute requirement for modern radiotherapy planning. Historically, structural imaging modalities have been used for this purpose, but there is a considerable role for functional imaging with PET/CT to contribute in this area. PET/CT's role in radiotherapy planning is well established and its use is indispensable in the clinical management of the lymphomas, particularly Hodgkin Lymphoma. A crucial use of PET/CT is as a baseline scan for delineation of the initial lymphomatous involvement, since this will determine the contouring of the gross-, clinical- and planning-target volumes (GTV, CTV, PTV). This article reviews the principles of contemporary radiotherapy, examines the evidence for the contribution of PET/CT to radiotherapy planning in lymphoma and the practicalities and challenges of applying this powerful technology to this situation.

引用

页码：162 / 171

页数：10

共 50 条

[1] Radiotherapy planning of lymphomas: role of metabolic imaging with PET/CT
Michael J. McKay
Kim L. Taubman
Szeting Lee
Andrew M. Scott
Annals of Nuclear Medicine, 2022, 36 : 162 - 171
[2] PET-CT radiotherapy planning in malignant lymphomas
Busetto, M
Stea, L
Gallo, L
Cracco, E
Marchetti, C
Gravili, S
Pizzi, G
RADIOTHERAPY AND ONCOLOGY, 2003, 68 : S119 - S119
[3] The role of PET/CT scanning in radiotherapy planning
Jarritt, P. H.
Carson, K. J.
Hounsell, A. R.
Visvikis, D.
BRITISH JOURNAL OF RADIOLOGY, 2006, 79 : S27 - S35
[4] The Current Role of PET/CT in Radiotherapy Planning
Lee, Sze Ting
Scott, Andrew M.
CURRENT RADIOPHARMACEUTICALS, 2015, 8 (01) : 38 - 44
[5] APPLICATION OF HYBRID PET-CT IMAGING IN RADIOTHERAPY PLANNING
Ratib, O.
STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 (11) : 624 - 624
[6] Role of PET/CT imaging in stereotactic body radiotherapy
Rajagopalan, Malolan S.
Heron, Dwight E.
FUTURE ONCOLOGY, 2010, 6 (02) : 305 - 317
[7] Metabolic Radiotherapy Planning with a dedicated FDG-PET-CT Scanner
Niyazi, M.
Landrock, S.
Elsner, A.
Hacker, M.
Belka, C.
Ganswindt, U.
STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 109 - 109
[8] Radiotherapy treatment planning based on functional PET/CT imaging data
Thorwarth, Daniela
NUCLEAR MEDICINE REVIEW, 2012, 15 : C43 - C47
[9] Planning Lung Radiotherapy Incorporating Motion Freeze PET/CT Imaging
Yang, Shih-Neng
Chiang, Wan-Chi
Chou, Kuei-Ting
Zhang, Geoffrey
Huang, Tzung-Chi
APPLIED SCIENCES-BASEL, 2018, 8 (09):
[10] THE IMPACT OF PET-CT IMAGING IN RADIOTHERAPY PLANNING FOR ESOPHAGEAL CANCER
Nishioka, A.
Ogawa, Y.
Kariya, S.
Tadokoro, M.
Nakatani, K.
Tsuzuki, K.
Ue, H.
Hamada, N.
Kubota, K.
Fukumoto, M.
RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S358 - S358

← 1 2 3 4 5 →